Progress in improving childhood cancer outcomes relies on regular, federal investment in childhood cancer research, including continued funding for the Childhood Cancer Survivorship, Treatment, Access, and Research (STAR) Act and Childhood Cancer Data Initiative (CCDI). ACS CAN is urging Congress to continue to make investments in improving childhood cancer outcomes in FY24, including fully funding the STAR Act and CCDI at $30 million and $50 million, respectively, and providing at least $51 billion for National Institutes of Health, including $9.988 billion for cancer research at the National Cancer Institute.
